Assembly Biosciences, Inc. (ASMB) stock
ASMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/309% below fair value
$22.50+1.21 (+5.68%)
Close on Nov 17, 2026Market cap $458.11MP/E –Yield –
Assembly Biosciences total assets
Total assets on the balance sheet at the end of each period.
Assembly Biosciences's total assets was $330.83M at Jun 30, 2026. For fiscal 2025 it was $257.59M, up 116.2% from the year before. Over ten years it grew 6.8% a year on average. The highest annual figure on record is $339.91M in fiscal 2019.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $257.59M | +116.2% |
| FY2024 | Dec 31, 2024 | $119.17M | -12.9% |
| FY2023 | Dec 31, 2023 | $136.82M | +34.4% |
| FY2022 | Dec 31, 2022 | $101.79M | -46.7% |
| FY2021 | Dec 31, 2021 | $191.06M | -32.5% |
| FY2020 | Dec 31, 2020 | $283.25M | -16.7% |
| FY2019 | Dec 31, 2019 | $339.91M | +26.8% |
| FY2018 | Dec 31, 2018 | $268.05M | +58.3% |
| FY2017 | Dec 31, 2017 | $169.30M | +72.6% |
| FY2016 | Dec 31, 2016 | $98.12M | -26.6% |
| FY2015 | Dec 31, 2015 | $133.74M | +87.8% |
| FY2014 | Dec 31, 2014 | $71.23M | +162.5% |
| FY2013 | Dec 31, 2013 | $27.13M | +32.0% |
| FY2012 | Dec 31, 2012 | $20.56M | -44.5% |
| FY2011 | Dec 31, 2011 | $37.05M | +153.5% |
| FY2010 | Dec 31, 2010 | $14.62M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $330.83M | +309.5% |
| Q1 FY2026 | Mar 31, 2026 | $235.51M | +137.8% |
| Q4 FY2025 | Dec 31, 2025 | $257.59M | +116.2% |
| Q3 FY2025 | Sep 30, 2025 | $240.00M | +139.4% |
| Q2 FY2025 | Jun 30, 2025 | $80.78M | -30.0% |
| Q1 FY2025 | Mar 31, 2025 | $99.02M | -17.4% |
| Q4 FY2024 | Dec 31, 2024 | $119.17M | -12.9% |
| Q3 FY2024 | Sep 30, 2024 | $100.26M | +94.2% |
| Q2 FY2024 | Jun 30, 2024 | $115.32M | +73.2% |
| Q1 FY2024 | Mar 31, 2024 | $119.88M | +44.2% |
| Q4 FY2023 | Dec 31, 2023 | $136.82M | +34.4% |
| Q3 FY2023 | Sep 30, 2023 | $51.63M | -57.5% |
| Q2 FY2023 | Jun 30, 2023 | $66.58M | -53.6% |
| Q1 FY2023 | Mar 31, 2023 | $83.12M | -48.9% |
| Q4 FY2022 | Dec 31, 2022 | $101.79M | -46.7% |
| Q3 FY2022 | Sep 30, 2022 | $121.52M | -51.2% |
| Q2 FY2022 | Jun 30, 2022 | $143.45M | -45.3% |
| Q1 FY2022 | Mar 31, 2022 | $162.73M | -41.7% |
| Q4 FY2021 | Dec 31, 2021 | $191.06M | -32.5% |
| Q3 FY2021 | Sep 30, 2021 | $248.97M | -18.7% |
| Q2 FY2021 | Jun 30, 2021 | $262.14M | -11.1% |
| Q1 FY2021 | Mar 31, 2021 | $278.90M | -11.0% |
| Q4 FY2020 | Dec 31, 2020 | $283.25M | -16.7% |
| Q3 FY2020 | Sep 30, 2020 | $306.31M | +37.1% |
| Q2 FY2020 | Jun 30, 2020 | $294.80M | +22.1% |
| Q1 FY2020 | Mar 31, 2020 | $313.31M | +20.9% |
| Q4 FY2019 | Dec 31, 2019 | $339.91M | +26.8% |
| Q3 FY2019 | Sep 30, 2019 | $223.35M | -21.1% |
| Q2 FY2019 | Jun 30, 2019 | $241.51M | +69.6% |
| Q1 FY2019 | Mar 31, 2019 | $259.25M | +66.2% |
| Q4 FY2018 | Dec 31, 2018 | $268.05M | +58.3% |
| Q3 FY2018 | Sep 30, 2018 | $282.98M | +152.0% |
| Q2 FY2018 | Jun 30, 2018 | $142.42M | +16.0% |
| Q1 FY2018 | Mar 31, 2018 | $156.02M | +16.2% |
| Q4 FY2017 | Dec 31, 2017 | $169.30M | +72.6% |
| Q3 FY2017 | Sep 30, 2017 | $112.31M | +2.9% |
| Q2 FY2017 | Jun 30, 2017 | $122.77M | – |
| Q1 FY2017 | Mar 31, 2017 | $134.28M | – |
| Q4 FY2016 | Dec 31, 2016 | $98.12M | – |
| Q3 FY2016 | Sep 30, 2016 | $109.13M | – |
See a number that looks wrong?